ERBB2 amplifications and mutations in 109 advanced breast cancer patients by next-generation sequencing.

Ami N. Shah,Brian S. Finkelman,Lorenzo Gerratana,Andrew A. Davis,Neelima Katam,Chenyu Lin,Kristen Carroll,Saya Jacob,Firas Wehbe,Michael J. Gurley,Fang Lin,Luis Z. Blanco,Elena Vagia,Leonidas C. Platanias,William J. Gradishar,Amir Behdad,Massimo Cristofanilli

ERBB2 amplifications and mutations in 109 advanced breast cancer patients by next-generation sequencing.

2020

Ami N. Shah
Brian S. Finkelman
Lorenzo Gerratana
Andrew A. Davis
Neelima Katam
Chenyu Lin
Kristen Carroll
Saya Jacob
Firas Wehbe
Michael J. Gurley
Fang Lin
Luis Z. Blanco
Elena Vagia
Leonidas C. Platanias
William J. Gradishar
Amir Behdad
Massimo Cristofanilli

3565Background: In advanced breast cancer (ABC) HER2 status is based on ASCO/CAP immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) criteria. Next generation sequencing (NGS) ...

Keywords:

Cancer
Internal medicine
Oncology
DNA sequencing
advanced breast
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations